ChemoMetec A/S

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:42 2024-04-26 am EDT			5-day change	1st Jan Change
286.6 ^DKK	+1.49%		+0.49%	-26.13%

Apr. 12	Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	CI
Apr. 12	ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	CI

Chemometec A/S Provides Earnings Guidance for the Year 2020/21

February 05, 2021 at 02:45 am EST

ChemoMetec A/S provided earnings guidance for the year 2020/21. The company raised revenue in the DKK 250-260 million range, up from DKK 240-250 million.

Latest news about ChemoMetec A/S

Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	Apr. 12	CI
ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	Apr. 12	CI
ChemoMetec Appoints COO as New CEO	Mar. 13	MT
ChemoMetec A/S Announces CEO Changes	Mar. 13	CI
Transcript : ChemoMetec A/S, H1 2024 Earnings Call, Feb 06, 2024	Feb. 06
ChemoMetec A/S Maintains Earnings Guidance for the Year 2024	Feb. 05	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 05	CI
ChemoMetec A/S Announces Executive Changes	Dec. 20	CI
Transcript : ChemoMetec A/S, 2023 Earnings Call, Sep 14, 2023	23-09-14
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-13	CI
Chemometec A/S Proposes Dividend for the 2022/23 Financial Year	23-09-13	CI
Chemometec A/S Provides Earnings Guidance for the 2023-2024 Financial Year	23-09-13	CI
ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023	23-05-08	CI
ChemoMetec A/S Appoints Rasmus Kofoed as CEO, Effective No Later Than 1 August 2023	23-04-17	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-08	CI
ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023	23-02-08	CI
Chemometec A/S Announces Resignation of Steen Søndergaard as CEO	22-12-14	CI
ChemoMetec A/S Provides Earnings Guidance for the Financial Year 2022-23	22-11-08	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-15	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-15	CI
ChemoMetec A/S Provides Revenue Guidance for the Fiscal Year 2023	22-09-15	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-08	CI
Chemometec A/S Reaffirms Earnings Guidance for the Financial Year 2021-2022	21-11-04	CI
ChemoMetec Appoints Bent Faurskov as New CFO from 1 October 2021	21-06-30	CI
Chemometec A/S Announces Unaudited Consolidated Earnings Results for the First Half Ended December 31, 2020	21-02-05	CI

Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Companyâs activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Companyâs analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for ChemoMetec A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

286.6 DKK

Average target price

462.5 DKK

Spread / Average Target

+61.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
CHEMOMETEC A/S	-26.13%	706M
SHOCKWAVE MEDICAL, INC.	+73.17%	12.34B
PENUMBRA, INC.	-18.74%	7.96B
MASIMO CORPORATION	+16.15%	7.16B
GETINGE AB	+4.81%	5.72B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+5.99%	5.03B
APT MEDICAL INC.	+27.07%	4.35B
ASAHI INTECC CO., LTD.	-21.67%	3.99B
INARI MEDICAL, INC.	-40.82%	2.21B
SKAN GROUP AG	+1.49%	2.01B

Medical Equipment

ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Chemometec A/S Provides Earnings Guidance for the Year 2020/21

Latest news about ChemoMetec A/S

Chart ChemoMetec A/S

Company Profile

Income Statement Evolution

Ratings for ChemoMetec A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Equipment